Gender differences in the renin-angiotensin and nitric oxide systems: Relevance in the normal and diseased kidney

Kidney and Blood Pressure Research

Volumn 30, Issue 2, 2007, Pages 67-80

  McGuire, Barry B ^a   Watson, R William G ^a   Pérez Barriocanal, Fernando ^a,c   Fitzpatrick, John M ^a,b   Docherty, Neil G ^a,d  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c UNIVERSITY OF SALAMANCA   (Spain)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Androgen; Nitric oxide; Oestrogen; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; DROSPIRENONE; ENALAPRIL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; ESTROGEN; FINASTERIDE; FLUTAMIDE; HEAT SHOCK PROTEIN 70; INTERCELLULAR ADHESION MOLECULE 1; LOSARTAN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; NITRIC OXIDE DONOR; RENIN; SODIUM CHANNEL; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA1;

ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CHRONIC ALLOGRAFT NEPHROPATHY; CYTOKINE PRODUCTION; ESTROGEN ACTIVITY; EXTRACELLULAR SPACE; FEMALE; HOMEOSTASIS; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; INFLAMMATORY INFILTRATE; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; NEPHRITIS; NONHUMAN; OBSTRUCTIVE UROPATHY; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR DISEASE; REPERFUSION INJURY; REVIEW; SEX DIFFERENCE; SURVIVAL; URETER OBSTRUCTION; VASOCONSTRICTION; VASODILATATION;

ANDROGENS; DISEASE PROGRESSION; ESTROGENS; FEMALE; HOMEOSTASIS; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; NITRIC OXIDE; RENIN-ANGIOTENSIN SYSTEM; SEX CHARACTERISTICS; VASODILATION;

EID: 34247580901     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099150     Document Type: Review

References (144)

1. Quinkler M, Bumke-Vogt C, Meyer B, Bahr V, Oelkers W, Diederich S: The human kidney is a progesterone-metabolizing and androgen-producing organ. J Clin Endocrinol Metab 2003;88:2803-2809.
2. Kimura N, Mizokami A, Oonuma T, Sasano H, Nagura H: Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem 1993;41:671-678.
3. Boulkroun S, Le Moellic C, Blot-Chabaud M, Farman N, Courtois-Coutry N: Expression of androgen receptor and androgen regulation of NDRG2 in the rat renal collecting duct. Pflügers Arch 2005;451:388-394.
4. Sharma PK, Thakur MK: Estrogen receptor alpha expression in mice kidney shows sex differences during aging. Biogerontology 2004;5:375-381.
5. Taylor AH, Al-Azzawi F: Immunolocalisation of oestrogen receptor beta in human tissues. J Mol Endocrinol 2000;24:145-155.
6. Potier M, Elliot SJ, Tack I, Lenz O, Striker GE, Striker LJ, Karl M: Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol 2001;12:241-251.
7. Sharma PK, Thakur MK: Expression of estrogen receptor (ER) alpha and beta in mouse cerebral cortex: effect of age, sex and gonadal steroids. Neurobiol Aging 2006;27:880-887.
8. Muller V, Szabo A, Viklicky O, Gaul I, Portl S, Philipp T, Heemann UW: Sex hormones and gender-related differences: their influence on chronic renal allograft rejection. Kidney Int 1999;55:2011-2020.
9. Muller V, Losonczy G, Heemann U, Vannay A, Fekete A, Reusz G, Tulassay T, Szabo AJ: Sexual dimorphism in renal ischemia-reperfusion injury in rats: possible role of endothelin. Kidney Int 2002;62:1364-1371.
10. Park KM, Kim JI, Ahn Y, Bonventre AJ, Bonventre JV: Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 2004;279:52282-52292.
11. Ishikawa I, Maeda K, Nakai S, Kawaguchi Y: Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2000;35:1072-1075.
12. Lane PH: Diabetic kidney disease: impact of puberty. Am J Physiol Renal Physiol 2002;283:F589-F600.
13. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000;11:319-329.
14. Silbiger SR, Neugarten J: The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 1995;25:515-533.
15. Cherney DZ, Sochett EB, Miller JA: Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int 2005;68:1722-1728.
16. Rosenmann E, Yanko L, Cohen AM: Female sex hormone and nephropathy in Cohen diabetic rat (genetically selected sucrose-fed). Horm Metab Res 1984;16:11-16.
17. Riazi S, Maric C, Ecelbarger CA:17-beta estradiol attenuates streptozotocin-induced diabetes and regulates the expression of renal sodium transporters. Kidney Int 2006;69:471-480.
18. Wells CC, Riazi S, Mankhey RW, Bhatti F, Ecelbarger C, Maric C: Diabetic nephropathy is associated with decreased circulating estradiol levels and imbalance in the expression of renal estrogen receptors. Gend Med 2005;2:227-237.
19. Mankhey RW, Bhatti F, Maric C: 17beta-estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol 2005;288:F399-F405.
20. Chin M, Isono M, Isshiki K, Araki S, Sugimoto T, Guo B, Sato H, Haneda M, Kashiwagi A, Koya D: Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice. Am J Pathol 2005;166:1629-1636.
21. Stevenson FT, Wheeldon CM, Gades MD, Kaysen GA, Stern JS, van Goor H: Estrogen worsens incipient hypertriglyceridemic glomerular injury in the obese Zucker rat. Kidney Int 2000;57:1927-1935.
22. Gades MD, Stern JS, van Goor H, Nguyen D, Johnson PR, Kaysen GA: Estrogen accelerates the development of renal disease in female obese Zucker rats. Kidney Int 1998;53:130-135.
23. Lindeman RD, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33:278-285.
24. Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA, Southern DA, McLaughlin K, Mortis G, Culleton BF: Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 2006;69:2155-2161.
25. Baylis C: Changes in renal hemodynamics and structure in the aging kidney; sexual dimorphism and the nitric oxide system. Exp Gerontol 2005;40:271-278.
26. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D: Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313.
27. August P, Oparil S: Hypertension in women. J Clin Endocrinol Metab 1999;84:1862-1866.
28. Tominaga T, Suzuki H, Ogata Y, Matsukawa S, Saruta T: The role of sex hormones and sodium intake in postmenopausal hypertension. J Hum Hypertens 1991;5:495-500.
29. Oelkers WH: Drospirenone in combination with estrogens: for contraception and hormone replacement therapy. Climacteric 2005;8(suppl 3):19-27.
30. Reckelhoff JF, Zhang H, Granger JP: Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 1998;31:435-439.
31. Quan A, Chakravarty S, Chen JK, Chen JC, Loleh S, Saini N, Harris RC, Capdevila J, Quigley R: Androgens augment proximal tubule transport. Am J Physiol Renal Physiol 2004;287:F452-F459.
32. Volk KA, Sigmund RD, Snyder PM, McDonald FJ, Welsh MJ, Stokes JB: rENaC is the predominant Na+ channel in the apical membrane of the rat renal inner medullary collecting duct. J Clin Invest 1995;96:2748-2757.
33. Quinkler M, Bujalska IJ, Kaur K, Onyimba CU, Buhner S, Allolio B, Hughes SV, Hewison M, Stewart PM: Androgen receptor-mediated regulation of the alpha-subunit of the epithelial sodium channel in human kidney. Hypertension 2005;46:787-798.
34. Qadri F, Culman J, Veltmar A, Maas K, Rascher W, Unger T: Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus. J Pharmacol Exp Ther 1993;267:567-574.
35. Klussmann E, Maric K, Rosenthal W: The mechanisms of aquaporin control in the renal collecting duct. Rev Physiol Biochem Pharmacol 2000;141:33-95.
36. Cairns HS, Rogerson ME, Fairbanks LD, Neild GH, Westwick J: Endothelin induces an increase in renal vascular resistance and a fall in glomerular filtration rate in the rabbit isolated perfused kidney. Br J Pharmacol 1989;98:155-160.
37. James GD, Sealey JE, Muller F, Alderman M, Madhavan S, Laragh JH: Renin relationship to sex, race and age in a normotensive population. J Hypertens Suppl 1986;4:S387-S389.
38. Ellison KE, Ingelfinger JR, Pivor M, Dzau VJ: Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest 1989;83:1941-1945.
39. Katz FH, Roper EF: Testosterone effect on renin system in rats. Proc Soc Exp Biol Med 1977;155:330-333.
40. Reckelhoff JF, Zhang H, Srivastava K: Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension 2000;35:480-483.
41. Reckelhoff JF, Zhang H, Srivastava K, Granger JP: Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 1999;34:920-923.
42. Garcia-Estan J, Atucha NM, Quesada T, Vargas F: Involvement of renin-angiotensin system in the reduced pressure natriuresis response of hyperthyroid rats. Am J Physiol 1995;268:E897-E901.
43. Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheugt FW, Gooren LJ: Influence of sex hormones on plasma endothelin levels. Ann Intern Med 1993;118:429-432.
44. Dean SA, Tan J, O'Brien ER, Leenen FH: 17beta-estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats. Am J Physiol Regul Integr Comp Physiol 2005;288:R759-R766.
45. Harrison-Bernard LM, Schulman IH, Raij L: Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity. Hypertension 2003;42:1157-1163.
46. Siragy HM, Xue C, Abadir P, Carey RM: Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation. Hypertension 2005;45:133-137.
47. Silva-Antonialli MM, Tostes RC, Fernandes L, Fior-Chadi DR, Akamine EH, Carvalho MH, Fortes ZB, Nigro D: A lower ratio of AT1/AT2 receptors of angiotensin II is found in female than in male spontaneously hypertensive rats. Cardiovasc Res 2004;62:587-593.
48. Gross V, Schunck WH, Honeck H, Milia AF, Kargel E, Walther T, Bader M, Inagami T, Schneider W, Luft FC: Inhibition of pressure natriuresis in mice lacking the AT2 receptor. Kidney Int 2000;57:191-202.
49. Hiyoshi H, Yayama K, Takano M, Okamoto H: Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension. Hypertension 2005;45:967-973.
50. Best PJ, Berger PB, Miller VM, Lerman A: The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 1998;128:285-288.
51. Miller JA, Cherney DZ, Duncan JA, Lai V, Burns KD, Kennedy CR, Zimpelmann J, Gao W, Cattran DC, Scholey JW: Gender differences in the renal response to renin-angiotensin system blockade. J Am Soc Nephrol 2006;17:2554-2560.
52. Gabbai FB, Blantz RC: Role of nitric oxide in renal hemodynamics. Semin Nephrol 1999;19:242-250.
53. Lahera V, Navarro-Cid J, Cachofeiro V, Garcia-Estan J, Ruilope LM: Nitric oxide, the kidney, and hypertension. Am J Hypertens 1997;10:129-140.
54. Forte P, Kneale BJ, Milne E, Chowienczyk PJ, Johnston A, Benjamin N, Ritter JM: Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension 1998;32:730-734.
55. Neugarten J, Ding Q, Friedman A, Lei J, Silbiger S: Sex hormones and renal nitric oxide synthases. J Am Soc Nephrol 1997;8:1240-1246.
56. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, Shaul PW: Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 2000;87:E44-E52.
57. Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, Adachi K, Tasaka K, Miyoshi E, Fujiwara N, Taniguchi N, Murata Y: Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 2001;276:3459-3467.
58. Wagner AH, Schroeter MR, Hecker M: 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 2001;15:2121-2130.
59. Florian M, Freiman A, Magder S: Treatment with 17-beta-estradiol reduces superoxide production in aorta of ovariectomized rats. Steroids 2004;69:779-787.
60. Chatterjee PK, Patel NS, Kvale EO, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Thiemermann C: Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 2002;61:862-871.
61. Rivas-Cabanero L, Rodriguez-Lopez AM, Martinez-Salgado C, Saura M, Lamas S, Lopez-Novoa JM: Gentamicin treatment increases mesangial cell nitric oxide production. Exp Nephrol 1997;5:23-30.
62. Martinez-Salgado C, Eleno N, Morales AI, Perez-Barriocanal F, Arevalo M, Lopez-Novoa JM: Gentamicin treatment induces simultaneous mesangial proliferation and apoptosis in rats. Kidney Int 2004;65:2161-2171.
63. Antus B, Yao Y, Liu S, Song E, Lutz J, Heemann U: Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone. Kidney Int 2001;60:1955-1963.
64. Antus B, Yao Y, Song E, Liu S, Lutz J, Heemann U: Opposite effects of testosterone and estrogens on chronic allograft nephropathy. Transpl Int 2002;15:494-501.
65. Takami H, Backer CL, Crawford SE, Zales VR, Mavroudis C: Influence of gender on allograft rejection in a rat heart transplant model. J Heart Lung Transplant 1995;14:529-536.
66. Ikee R, Kobayashi S, Hemmi N, Imakiire T, Kikuchi Y, Moriya H, Suzuki S, Miura S: Correlation between the resistive index by Doppler ultrasound and kidney function and histology. Am J Kidney Dis 2005;46:603-609.
67. Basile DP: Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy. Curr Opin Nephrol Hypertens 2004;13:1-7.
68. Radermacher J, Mengel M, Ellis S, Stuht S, Hiss M, Schwarz A, Eisenberger U, Burg M, Luft FC, Gwinner W, Haller H: The renal arterial resistance index and renal allograft survival. N Engl J Med 2003;349:115-124.
69. Tharaux PL, Chatziantoniou C, Casellas D, Fouassier L, Ardaillou R, Dussaule JC: Vascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats. Circulation 1999;99:2185-2191.
70. Hegarty NJ, Young LS, O'Neill AJ, Watson RW, Fitzpatrick JM: Endothelin in unilateral ureteral obstruction: vascular and cellular effects. J Urol 2003;169:740-744.
71. Torres M, Forman HJ: Redox signaling and the MAP kinase pathways. Biofactors 2003;17:287-296.
72. Chakraborti S, Chakraborti T: Oxidant-mediated activation of mitogen-activated protein kinases and nuclear transcription factors in the cardiovascular system: a brief overview. Cell Signal 1998;10:675-683.
73. Martin CJ, Goeddeke-Merickel CM: Oxidative stress in chronic kidney disease. Nephrol Nurs J 2005;32:683-685.
74. Himmelfarb J: Relevance of oxidative pathways in the pathophysiology of chronic kidney disease. Cardiol Clin 2005;23:319-330.
75. Percy C, Waters MJ, Gobe G: Caveolins in the repair phase of acute renal failure after oxidative stress. Nephrology (Carlton) 2004;9:374-380.
76. Lacy F, Kailasam MT, O'Connor DT, Schmid-Schonbein GW, Parmer RJ: Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 2000;36:878-884.
77. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-1148.
78. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, Munzel T: Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002;90:E58-E65.
79. Pechter U, Aunapuu M, Riispere Z, Vihalemm T, Kullissaar T, Zilmer K, Zilmer M, Ots M: Oxidative stress status in kidney tissue after losartan and atenolol treatment in experimental renal failure. Nephron Exp Nephrol 2004;97:e33-e37.
80. Sugiyama H, Kobayashi M, Wang DH, Sunami R, Maeshima Y, Yamasaki Y, Masuoka N, Kira S, Makino H: Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Nephrol Dial Transplant 2005;20:2670-2680.
81. Yavuz D, Kucukkaya B, Haklar G, Ersoz O, Akoglu E, Akalin S: Effects of captopril and losartan on lipid peroxidation, protein oxidation and nitric oxide release in diabetic rat kidney. Prostaglandins Leukot Essent Fatty Acids 2003;69:223-227.
82. Schneider R, Raff U, Vornberger N, Schmidt M, Freund R, Reber M, Schramm L, Gambaryan S, Wanner C, Schmidt HH, Galle J: L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int 2003;64:216-225.
83. Zhang JJ, Bledsoe G, Kato K, Chao L, Chao J: Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress. Kidney Int 2004;66:722-732.
84. Chao HH, Chen JJ, Chen CH, Lin H, Cheng CF, Lian WS, Chen YL, Juan SH, Liu JC, Liou JY, Chan P, Cheng TH: Inhibition of angiotensin II induced endothelin-1 gene expression by 17-beta-oestradiol in rat cardiac fibroblasts. Heart 2005;91:664-669.
85. Pleskova M, Beck KF, Behrens MH, Huwiler A, Fichtlscherer B, Wingerter O, Brandes RP, Mulsch A, Pfeilschifter J: Nitric oxide downregulates the expression of the catalytic NADPH oxidase subunit Nox1 in rat renal mesangial cells. FASEB J 2006;20:139-141.
86. Muzandu K, Shaban Z, Ishizuka M, Kazusaka A, Fujita S: Nitric oxide enhances catechol estrogen-induced oxidative stress in LNCaP cells. Free Radic Res 2005;39:389-398.
87. Dawling S, Hachey DL, Roodi N, Parl FF: In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol. Chem Res Toxicol 2004;17:1258-1264.
88. Eckardt KU, Bernhardt WM, Weidemann A, Warnecke C, Rosenberger C, Wiesener MS, Willam C: Role of hypoxia in the pathogenesis of renal disease. Kidney Int Suppl 2005:S46-S51.
89. Nangaku M: Hypoxia and tubulointerstitial injury: a final common pathway to endstage renal failure. Nephron Exp Nephrol 2004;98:e8-e12.
90. Docherty NG, O'Sullivan OE, Healy DA, Fitzpatrick JM, Watson RW: Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am J Physiol Renal Physiol 2006;290:F4-F13.
91. Gandolfo MT, Verzola D, Salvatore F, Gianiorio G, Procopio V, Romagnoli A, Giannoni M, Garibotto G: Gender and the progression of chronic renal diseases: does apoptosis make the difference? Minerva Urol Nefrol 2004;56:1-14.
92. Verzola D, Gandolfo MT, Salvatore F, Villaggio B, Gianiorio F, Traverso P, Deferrari G, Garibotto G: Testosterone promotes apoptotic damage in human renal tubular cells. Kidney Int 2004;65:1252-1261.
93. Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, Singhal PC: Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 2003;284:F955-F965.
94. Jones EA, Shahed A, Shoskes DA: Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction. Urology 2000;56:346-351.
95. Guo G, Morrissey J, McCracken R, Tolley T, Liapis H, Klahr S: Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am J Physiol Renal Physiol 2001;280:F777-F785.
96. Blush J, Lei J, Ju W, Silbiger S, Pullman J, Neugarten J: Estradiol reverses renal injury in Alb/TGF-beta1 transgenic mice. Kidney Int 2004;66:2148-2154.
97. Martinez-Mier G, Toledo-Pereyra LH, Bussell S, Gauvin J, Vercruysse G, Arab A, Harkema JR, Jordan JA, Ward PA: Nitric oxide diminishes apoptosis and p53 gene expression after renal ischemia and reperfusion injury. Transplantation 2000;70:1431-1437.
98. Ito K, Chen J, Seshan SV, Khodadadian JJ, Gallagher R, Chaar ME, Vaughan ED Jr, Poppas DP, Felsen D: Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats. Kidney Int 2005;68:515-528.
99. Miyajima A, Chen J, Poppas DP, Vaughan ED Jr, Felsen D: Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int 2001;59:1290-1303.
100. Du C, Guan Q, Diao H, Yin Z, Jevnikar AM: Nitric oxide induces apoptosis in renal tubular epithelial cells through activation of caspase-8. Am J Physiol Renal Physiol 2006;290:F1044-F1054.
101. Chanvorachote P, Nimmannit U, Wang L, Stehlik C, Lu B, Azad N, Rojanasakul Y: Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory protein. J Biol Chem 2005;280:42044-42050.
102. Uriarte SM, Joshi-Barve S, Song Z, Sahoo R, Gobejishvili L, Jala VR, Haribabu B, McClain C, Barve S: Akt inhibition upregulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes. Cell Death Differ 2005;12:233-242.
103. Koga M, Hirano K, Hirano M, Nishimura J, Nakano H, Kanaide H: Akt plays a central role in the anti-apoptotic effect of estrogen in endothelial cells. Biochem Biophys Res Commun 2004;324:321-325.
104. Yoon SJ, Choi KH, Lee KA: Nitric oxide-mediated inhibition of follicular apoptosis is associated with HSP70 induction and Bax suppression. Mol Reprod Dev 2002;61:504-510.
105. Voss MR, Stallone JN, Li M, Cornelussen RN, Knuefermann P, Knowlton AA: Gender differences in the expression of heat shock proteins: the effect of estrogen. Am J Physiol Heart Circ Physiol 2003;285:H687-H692.
106. Healy DA, Daly PJ, Docherty NG, Murphy M, Fitzpatrick JM, Watson RW: Heat shock-induced protection of renal proximal tubular epithelial cells from cold storage and rewarming injury. J Am Soc Nephrol 2006;17:805-812.
107. Matsumori Y, Northington FJ, Hong SM, Kayama T, Sheldon RA, Vexler ZS, Ferriero DM, Weinstein PR, Liu J: Reduction of caspase-8 and -9 cleavage is associated with increased c-FLIP and increased binding of Apaf-1 and Hsp70 after neonatal hypoxic/ischemic injury in mice overexpressing Hsp70. Stroke 2006;37:507-512.
108. Hegarty NJ, Watson RW, Young LS, O'Neill AJ, Brady HR, Fitzpatrick JM: Cytoprotective effects of nitrates in a cellular model of hydronephrosis. Kidney Int 2002;62:70-77.
109. Chiueh C, Lee S, Andoh T, Murphy D: Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen. Endocrine 2003;21:27-31.
110. Van Kooten C, Daha MR, van Es LA: Tubular epithelial cells: a critical cell type in the regulation of renal inflammatory processes. Exp Nephrol 1999;7:429-437.
111. Healy E, Leonard M, Madrigal-Estebas L, O'Farrelly C, Watson AJ, Ryan MP: Factors produced by activated leukocytes alter renal epithelial cell differentiation. Kidney Int 1999;56:1266-1269.
112. Lange-Sperandio B, Fulda S, Vandewalle A, Chevalier RL: Macrophages induce apoptosis in proximal tubule cells. Pediatr Nephrol 2003;18:335-341.
113. Tanifuji C, Suzuki Y, Geot WM, Horikoshi S, Sugaya T, Ruiz-Ortega M, Egido J, Tomino Y: Reactive oxygen species-mediated signaling pathways in angiotensin II-induced MCP-1 expression of proximal tubular cells. Antioxid Redox Signal 2005;7:1261-1268.
114. Xie QY, Ming S, Yang TL, Sun ZL: Losartan reduces monocyte chemoattractant protein-1 expression in aortic tissues of 2K1C hypertensive rats. Int J Cardiol 2006;110:60-66.
115. Kanda N, Watanabe S:17Beta-estradiol inhibits MCP-1 production in human keratinocytes. J Invest Dermatol 2003;120:1058-1066.
116. Kovacs EJ, Faunce DE, Ramer-Quinn DS, Mott FJ, Dy PW, Frazier-Jessen MR: Estrogen regulation of JE/MCP-1 mRNA expression in fibroblasts. J Leukoc Biol 1996;59:562-568.
117. Desai A, Zhao Y, Lankford HA, Warren JS: Nitric oxide suppresses EPO-induced monocyte chemoattractant protein-1 in endothelial cells: implications for atherogenesis in chronic renal disease. Lab Invest 2006;86:369-379.
118. Ikeda M, Ikeda U, Takahashi M, Shimada K, Minota S, Kano S: Nitric oxide inhibits intracellular adhesion molecule-1 expression in rat mesangial cells. J Am Soc Nephrol 1996;7:2213-2218.
119. Liu HQ, Wei XB, Sun R, Cai YW, Lou HY, Wang JW, Chen AF, Zhang XM: Angiotensin II stimulates intercellular adhesion molecule-1 via an AT1 receptor/nuclear factor-kappaB pathway in brain microvascular endothelial cells. Life Sci 2006;78:1293-1298.
120. Galea E, Santizo R, Feinstein DL, Adamsom P, Greenwood J, Koenig HM, Pelligrino DA: Estrogen inhibits NF kappa B-dependent inflammation in brain endothelium without interfering with I kappa B degradation. Neuroreport 2002;13:1469-1472.
121. Waldow T, Witt W, Weber E, Matschke K: Nitric oxide donor-induced persistent inhibition of cell adhesion protein expression and NFkappaB activation in endothelial cells. Nitric Oxide 2006;15:103-113.
122. Chen Y, Arrigo AP, Currie RW: Heat shock treatment suppresses angiotensin II-induced activation of NF-kappaB pathway and heart inflammation: a role for IKK depletion by heat shock? Am J Physiol Heart Circ Physiol 2004;287:H1104-H1114.
123. Feinstein DL, Galea E, Aquino DA, Li GC, Xu H, Reis DJ: Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFkappaB activation. J Biol Chem 1996;271:17724-17732.
124. Kan W, Zhao KS, Jiang Y, Yan W, Huang Q, Wang J, Qin Q, Huang X, Wang S: Lung, spleen, and kidney are the major places for inducible nitric oxide synthase expression in endotoxic shock: role of p38 mitogen-activated protein kinase in signal transduction of inducible nitric oxide synthase expression. Shock 2004;21:281-287.
125. Eberhardt W, Pluss C, Hummel R, Pfeilschifter J: Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells. J Immunol 1998;160:4961-4969.
126. Walker LM, Walker PD, Imam SZ, Ali SF, Mayeux PR: Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-iminoethyl)-lysine. J Pharmacol Exp Ther 2000;295:417-422.
127. Park EM, Cho S, Frys KA, Glickstein SB, Zhou P, Anrather J, Ross ME, Iadecola C: Inducible nitric oxide synthase contributes to gender differences in ischemic brain injury. J Cereb Blood Flow Metab 2006;26:392-401.
128. Buttner C, Skupin A, Rieber EP: Transcriptional activation of the type I collagen genes COL1A1 and COL1A2 in fibroblasts by interleukin-4: analysis of the functional collagen promoter sequences. J Cell Physiol 2004;198:248-258.
129. Bohle A, Muller GA, Wehrmann M, Mackensen-Haen S, Xiao JC: Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int Suppl 1996;54:S2-S9.
130. Gharaee-Kermani M, Hatano K, Nozaki Y, Phan SH: Gender-based differences in bleomycin-induced pulmonary fibrosis. Am J Pathol 2005;166:1593-1606.
131. Birch Nielsen C, Krag S, Osterby R, Flyvbjerg A, Nyengaard J, Forman A, Wogensen L: Transforming growth factor beta1-induced glomerulopathy is prevented by 17beta-estradiol supplementation. Virchows Arch 2004;444:561-566.
132. Xu JW, Gong J, Chang XM, Luo JY, Dong L, Hao ZM, Jia A, Xu GP: Estrogen reduces CCL4-induced liver fibrosis in rats. World J Gastroenterol 2002;8:883-887.
133. Liu Y: Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006;69:213-217.
134. Gill RK, Turner RT, Wronski TJ, Bell NH: Orchiectomy markedly reduces the concentration of the three isoforms of transforming growth factor beta in rat bone, and reduction is prevented by testosterone. Endocrinology 1998;139:546-550.
135. Olsen NJ, Zhou P, Ong H, Kovacs WJ: Testosterone induces expression of transforming growth factor-beta 1 in the murine thymus. J Steroid Biochem Mol Biol 1993;45:327-332.
136. Gibbons GH, Pratt RE, Dzau VJ: Vascular smooth muscle cell hypertrophy vs. hyperplasia: autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest 1992;90:456-461.
137. Border WA, Noble NA: Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 1998;31:181-188.
138. Pimentel JL Jr, Sundell CL, Wang S, Kopp JB, Montero A, Martinez-Maldonado M: Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy. Kidney Int 1995;48:1233-1246.
139. Yayama K, Makino J, Takano M, Okamoto H: Role of angiotensin II in the transforming growth factor-beta 1 expression of rat kidney in anti-glomerular basement membrane antiserum-induced glomerulonephritis. Biol Pharm Bull 1995;18:687-690.
140. Shihab FS, Bennett WM, Tanner AM, Andoh TF: Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int 1997;52:660-673.
141. Manucha W, Oliveros L, Carrizo L, Seltzer A, Valles P: Losartan modulation on NOS isoforms and COX-2 expression in early renal fibrogenesis in unilateral obstruction. Kidney Int 2004;65:2091-2107.
142. Magoffin DA, Hubert-Leslie D, Zachow RJ: Estradiol-17 beta, insulin-like growth factor-I, and luteinizing hormone inhibit secretion of transforming growth factor beta by rat ovarian theca-interstitial cells. Biol Reprod 1995;53:627-635.
143. Neugarten J, Acharya A, Lei J, Silbiger S: Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. Am J Physiol Renal Physiol 2000;279:F309-F318.
144. Saura M, Zaragoza C, Herranz B, Griera M, Diez-Marques L, Rodriguez-Puyol D, Rodriguez-Puyol M: Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells. Circ Res 2005;97:1115-1123.